- Report
- November 2025
- 372 Pages
Global
From €5261EUR$5,850USD£4,634GBP
- Report
- November 2025
- 390 Pages
Global
From €5261EUR$5,850USD£4,634GBP
- Report
- November 2025
- 382 Pages
Global
From €5261EUR$5,850USD£4,634GBP
- Report
- November 2025
- 282 Pages
Global
From €5261EUR$5,850USD£4,634GBP
- Report
- November 2025
- 399 Pages
Global
From €5261EUR$5,850USD£4,634GBP
- Report
- November 2025
- 193 Pages
Global
From €5261EUR$5,850USD£4,634GBP
- Report
- November 2025
- 193 Pages
Global
From €5261EUR$5,850USD£4,634GBP
- Report
- October 2025
- 198 Pages
Global
From €3188EUR$3,545USD£2,808GBP
€3543EUR$3,939USD£3,120GBP
- Report
- October 2025
- 180 Pages
Global
From €3188EUR$3,545USD£2,808GBP
€3543EUR$3,939USD£3,120GBP
- Report
- October 2025
- 194 Pages
Global
From €3188EUR$3,545USD£2,808GBP
€3543EUR$3,939USD£3,120GBP
- Report
- October 2025
- 191 Pages
Global
From €3188EUR$3,545USD£2,808GBP
€3543EUR$3,939USD£3,120GBP
- Report
- October 2025
- 199 Pages
Global
From €3188EUR$3,545USD£2,808GBP
€3543EUR$3,939USD£3,120GBP
- Report
- October 2025
- 182 Pages
Global
From €3188EUR$3,545USD£2,808GBP
€3543EUR$3,939USD£3,120GBP
- Report
- October 2025
- 192 Pages
Global
From €3188EUR$3,545USD£2,808GBP
€3543EUR$3,939USD£3,120GBP
- Report
- October 2025
- 196 Pages
Global
From €3188EUR$3,545USD£2,808GBP
€3543EUR$3,939USD£3,120GBP
- Report
- October 2025
- 195 Pages
Global
From €3188EUR$3,545USD£2,808GBP
€3543EUR$3,939USD£3,120GBP
- Report
- October 2025
- 184 Pages
Global
From €3188EUR$3,545USD£2,808GBP
€3543EUR$3,939USD£3,120GBP
- Report
- October 2025
- 187 Pages
Global
From €3188EUR$3,545USD£2,808GBP
€3543EUR$3,939USD£3,120GBP
- Report
- October 2025
- 194 Pages
Global
From €3188EUR$3,545USD£2,808GBP
€3543EUR$3,939USD£3,120GBP
- Report
- October 2025
- 188 Pages
Global
From €3188EUR$3,545USD£2,808GBP
€3543EUR$3,939USD£3,120GBP

High Throughput Screening (HTS) is a technology used in the diagnostics market to rapidly identify compounds that interact with a target of interest. HTS is used to identify potential drug candidates, biomarkers, and other molecules that can be used in diagnostics. It is a powerful tool for drug discovery and development, as it can quickly identify compounds that interact with a target of interest. HTS can also be used to identify potential biomarkers for diagnostics, as it can quickly identify molecules that interact with a target of interest.
HTS is used in a variety of diagnostic applications, including cancer diagnostics, infectious disease diagnostics, and genetic diagnostics. HTS can be used to identify potential drug candidates, biomarkers, and other molecules that can be used in diagnostics.
Some companies in the HTS market include Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, and Thermo Fisher Scientific. Show Less Read more